Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

Pharmacy-led programme improves surgery outcomes for patients with diabetes

Glycaemic control programme improves post-surgery outcomes for diabetic patients.

US researchers found that a pharmacy-led glycaemic control programme improved postsurgical outcomes for such patients. In the image, surgeons operate on a patient

Source: Shutterstock.com

Patients who undergo surgery are at increased risk of complications if they have diabetes

Patients with diabetes and stress-induced hyperglycaemia are at increased risk of complications following surgery.

Researchers from the Kaiser Permanente Center for Health Research in Portland, Oregon, found that a pharmacy-led glycaemic control programme improved post-surgical outcomes for such patients.

The programme involved a team of dedicated ‘glycaemic pharmacists’, who were available seven days a week to manage intravenous insulin, calculate insulin doses, and manage parenteral nutrition, among other responsibilities.

Compared with a cohort of patients who underwent surgery before the programme was introduced, patients treated in the programme were more likely to have good glycaemic control after surgery (odds ratio [OR] 2.24 in year 1; 95% confidence interval [CI] 1.85–2.72; P<0.0001) and were less likely to develop hypoglycaemia (OR 0.38 in year 1; 95% CI 0.31–0.46; P<0.0001).

Patients treated in the programme were also less likely to require readmission in the three months following surgery and incurred lower medical costs during six-month follow up.

In American Journal of Pharmacy Benefits[1] (2015;7:e126–e134), the researchers say such programmes could help reduce variability around the implementation of glycaemic control guidelines. 

Citation: Clinical Pharmacist DOI: 10.1211/PJ.2015.20200111

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.